A marijuana based epilepsy drug backed by the FDA could become the first drug derived from cannabis to become legal for medical use at the federal level in the U.S. Epidolex recently received a boost from Food and Drug Administration staff.
A U.K. company GW Pharmaceuticals Plc created the drug and was able to provide “substantial evidence” of it’s effectiveness. The medication is designed to treat seizures associated with two rare forms of epilepsy that typically affect children.
“The risk-benefit profile established by the data in the application appears to support approval of cannabidiol,” FDA staff wrote.
The new medication is made from a chemical found in marijuana called “cannabidiol.” This is not the same as a tetrahydrocannabinol, or THC, which gives marijuana the euphoric effect that makes people feel “high”.